Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM1 | Q13255 | 13/20 | 0.44 |
| ▸ | GRM4 | Q14833 | 13/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | BRD1 | O95696 | 1/20 | 0.35 |
| ▸ | TAF1 | P21675 | 1/20 | 0.35 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL551232 | 0.92 | GRM1 (0.46) | GRM1GRM4LMNASMN1; SMN2GRM7 | |
| SCHEMBL2889309 | 0.82 | GRM1 (0.41) | GRM1GRM4LMNASMN1; SMN2GRM7 | |
| SCHEMBL2887938 | 0.81 | GRM1 (0.40) | GRM1GRM4LMNASMN1; SMN2GRM7 | |
| SCHEMBL5429466 | 0.80 | GRM1 (0.51) | GRM1GRM4LMNASMN1; SMN2GRM7 | |
| SCHEMBL2889428 | 0.78 | GRM1 (0.41) | GRM1GRM4LMNASMN1; SMN2GRM7 | |
| SCHEMBL2891957 | 0.78 | GRM1 (0.41) | GRM1GRM4LMNASMN1; SMN2GRM7 | |
| SCHEMBL2892277 | 0.77 | GRM1 (0.44) | GRM1GRM4LMNASMN1; SMN2GRM7 | |
| SCHEMBL3327139 | 0.76 | GRM1 (0.40) | GRM1GRM4LMNASMN1; SMN2GRM7 | |
| SCHEMBL2889604 | 0.76 | GRM1 (0.44) | GRM1GRM4LMNASMN1; SMN2GRM7 | |
| SCHEMBL2884250 | 0.75 | GRM4 (0.41) | GRM1GRM4LMNASMN1; SMN2GRM7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110689-B2 | Benzanilides with insecticidal activity | BAYER CROPSCIENE AG (DE) | 2012-02-07 | — | — | US | disclosed |
| US-20100062937-A1 | BENZANILIDES WITH INSECTICIDAL ACTIVITY | BAYER CROPSCIENCE AG (DE) | 2010-03-11 | — | — | US | disclosed |
| EP-1893567-A1 | BENZANILIDES WITH INSECTICIDAL ACTIVITY | Bayer CropScience AG (DE) | 2008-03-05 | — | — | EP | disclosed |
| WO-2006133823-A1 | BENZANILIDES WITH INSECTICIDAL ACTIVITY | BAYER CROPSCIENCE AG (DE) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100062937-A1 | BENZANILIDES WITH INSECTICIDAL ACTIVITY | CBR3, HCN3, HAX1 | GRM1 4419/4885GRM4 4646/4885LMNA 823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.